About
Research
Patient Care
Education
Community
Oct 10, 2023
University of California, Irvine researchers awarded $2.4 million 'Fast Track' grant to develop a novel cancer immunotherapy treatment
The University of California, Irvine, has been awarded a $2.4 million ‘Fast Track’ Small Business Technology Transfer (STTR) grant from the National Cancer Institute (NCI) to further develop a highly novel cancer immunotherapy treatment. The project, a joint grant with GlyTR Therapeutics Inc, will build upon work at UCI originally funded by the President Biden Cancer Moonshot Program.
Oct 08, 2023
Childhood Cancer Survivors at High Risk of Lifelong Health Challenges, Study Finds
"Another issue for childhood cancer survivors is mental health, with depression rates of 2.3 to 40.8 percent, much higher than the national average of 9.6 percent. They had a greater suicide risk, especially those 28 and older. Adults who survived childhood cancer had a 1.4-fold higher suicide risk than the overall population."
October 4, 2023 Bulletin
Events, Announcements & Funding Opportunities
October 04, 2023
Sep 26, 2023
Unlocking the Potential of T Cells: A New Breakthrough in Chronic Infections and Cancer
Assistant Professor Roberto Tinoco and his UC Irvine research team have made a groundbreaking discovery regarding the vital role of a protein called High Mobility Group Box 2 (HMGB2), which was recently published in Nature Communications.
September 20, 2023 Bulletin
September 20, 2023
Sep 19, 2023
UCI awarded $2.4 million grant to study potential treatment for cancer-related cognitive impairment
UCI has been awarded a five-year, $2.4 million grant from the National Cancer Institute to evaluate the augmentation of brain-derived neurotropic factor to alleviate cancer-related cognitive impairment. This multi-PI project translates findings from past human studies conducted by Alexandre Chan, Pharm.D., M.P.H., principal investigator and chair and professor of clinical pharmacy practice, into the laboratory, with the goal of evaluating the feasibility of enhancing the BDNF protein as a potential strategy for mitigating chemobrain. The study is being conducted in partnership with Munjal Acharya, M.S., Ph.D., associate professor of anatomy and neurobiology.
Sep 15, 2023
Professor Matthew Griffin Receives V Scholar for Cancer Research Award
Professor Matthew Griffin of the UC Irvine Department of Chemistry recently won the V Scholar for Cancer Research Award from the V Foundation — a charity founded in 1993 by ESPN and basketball coach Jim Valvano. This national award recognizes young tenure-track faculty who are early in their cancer research careers.
Sep 14, 2023
UC Irvine’s Dr. Shawn Griffin and CSU Fullerton Student Gloria Castañón Researching Health Disparities in Hispanic Populations; Connected Through Cancer Health Equity Research Partnership (CHERP)
Two Orange County universities have partnered to explore cancer disparities in the area, and for Castañón and University of California, Irvine’s Dr. Shawn Griffin, the program has provided a chance to conduct research they feel passionately about.
Sep 08, 2023
Why the rare skin cancer that killed Jimmy Buffett may become more common
Climate change may directly or indirectly contribute to rising skin cancer cases. … In the 1970s, [UCI] scientists started noticing holes in the ozone layer. Further investigation showed that artificial compounds such as chlorofluorocarbons were destroying ozone. … While Merkel cell carcinoma is more aggressive than melanoma, it is curable if caught early and treated successfully, says Ling Gao, an associate professor of dermatology at the University of California, Irvine. “For all skin cancers, early diagnosis greatly improves outcomes.”
September 6, 2023 Bulletin
September 06, 2023